InfuSystem (NYSEAMERICAN:INFU) Shares Pass Above Two Hundred Day Moving Average of $0.00

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $7.97. InfuSystem shares last traded at $7.78, with a volume of 18,679 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Wednesday, April 17th.

InfuSystem Price Performance

The company has a debt-to-equity ratio of 0.56, a current ratio of 1.95 and a quick ratio of 1.54. The stock has a market cap of $165.40 million, a PE ratio of 259.42 and a beta of 1.24.

Institutional Investors Weigh In On InfuSystem

Several large investors have recently made changes to their positions in INFU. Wasatch Advisors LP increased its holdings in shares of InfuSystem by 3.4% in the fourth quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock valued at $8,923,000 after purchasing an additional 27,881 shares during the last quarter. Ranger Investment Management L.P. boosted its position in shares of InfuSystem by 4.7% in the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock valued at $7,271,000 after acquiring an additional 30,835 shares during the period. First Eagle Investment Management LLC grew its stake in shares of InfuSystem by 14.7% in the fourth quarter. First Eagle Investment Management LLC now owns 537,214 shares of the medical instruments supplier’s stock valued at $5,662,000 after acquiring an additional 68,814 shares in the last quarter. Citigroup Inc. increased its position in InfuSystem by 124.1% during the third quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 28,038 shares during the period. Finally, WINTON GROUP Ltd bought a new position in shares of InfuSystem during the third quarter worth approximately $101,000. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.